MS-SMART

Multiple sclerosis - secondary progressive multi-arm randomisation trial

• A multi-arm phase IIb randomised, double blind placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.

• Complete

• Prof Siddharthan Chandran

• Prof Ian Marshall
• Dr Scott Semple

• Multiple Sclerosis (MS)

• EIF QMRI

• Multi-centre randomised placebo-control study

• Medical Research Council (MRC)
• MS society
• National Institute for Health Research (NIHR)
• National Institute for Health Research University College London Hospitals Biomedical Research Centre
• Sanofi
• University College London
• University of Edinburgh